These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21311244)

  • 1. Withdrawal of propoxyphene from the US market: implications for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2011; 25(2):55-6. PubMed ID: 21311244
    [No Abstract]   [Full Text] [Related]  

  • 2. Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market.
    Puet B; DePriest A; Knight J; Heltsley R; Black DL; Caplan YH; Cone EJ
    J Anal Toxicol; 2013; 37(1):1-4. PubMed ID: 23129731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal poisonings involving propoxyphene before and after voluntary withdrawal from the United States' market: An analysis from the state of Florida.
    Delcher C; Chen G; Wang Y; Slavova S; Goldberger BA
    Forensic Sci Int; 2017 Nov; 280():228-232. PubMed ID: 29080523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextropropoxyphene: withdrawal from the US market requested: harmful drug.
    Prescrire Int; 2009 Aug; 18(102):166-7. PubMed ID: 19746529
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of propoxyphene withdrawal on opioid use in veterans.
    Hayes CJ; Hudson TJ; Phillips MM; Bursac Z; Williams JS; Austin MA; Edlund MJ; Martin BC
    Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1180-8. PubMed ID: 26248742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A journey toward clinical nurse specialist recognition by Medicare: benefits of core clinical nurse specialist certification.
    Albaugh J
    Clin Nurse Spec; 2010; 24(4):219-21. PubMed ID: 20526123
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to Propoxyphene Market Withdrawal: Analgesic Substitutes, Doses, and Adverse Events.
    Jeffery MM; Morden NE; Larochelle M; Shah ND; Hooten WM; Meara E
    Med Care; 2020 Jan; 58(1):4-12. PubMed ID: 31651743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical nurse specialist profile. Interview by Jo Ellen Rust.
    Vollman K
    Clin Nurse Spec; 2010; 24(4):222-3. PubMed ID: 20526124
    [No Abstract]   [Full Text] [Related]  

  • 9. It is time to remove propoxyphene from clinical practice.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2009; 23(2):104-5. PubMed ID: 19492210
    [No Abstract]   [Full Text] [Related]  

  • 10. Food and Drug Administration recommends against the continued use of propoxyphene.
    Food And Drug Administration Public Health Service U S Department Of Health And Human Services
    J Pain Palliat Care Pharmacother; 2011; 25(1):80-2. PubMed ID: 21426228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity.
    Barkin RL; Barkin SJ; Barkin DS
    Am J Ther; 2006; 13(6):534-42. PubMed ID: 17122535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is a clinical nurse specialist?
    Lampe J
    Fla Nurse; 2013 Jun; 61(2):18. PubMed ID: 23905504
    [No Abstract]   [Full Text] [Related]  

  • 13. A trend analysis of laboratory positive propoxyphene workplace urine drug screens before and after the product recall.
    Price J
    J Addict Med; 2015; 9(2):136-8. PubMed ID: 25622125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In brief: propoxyphene toxicity.
    Med Lett Drugs Ther; 2010 Sep; 52(1346):69. PubMed ID: 20814401
    [No Abstract]   [Full Text] [Related]  

  • 15. The electronic health record and "meaningful use": implications for the clinical nurse specialist.
    Barton AJ
    Clin Nurse Spec; 2011; 25(1):8-10. PubMed ID: 21139460
    [No Abstract]   [Full Text] [Related]  

  • 16. Why pick on propoxyphene? The evidence demands it.
    Hutchison LC
    J Ark Med Soc; 2010 Aug; 107(2):36-7. PubMed ID: 20806582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption.
    Gaubert S; Vié M; Damase-Michel C; Pathak A; Montastruc JL
    Fundam Clin Pharmacol; 2009 Apr; 23(2):247-52. PubMed ID: 19298233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propoxyphene use in the elderly.
    Desai AK; Chibnall JT
    J Am Geriatr Soc; 2004 Jul; 52(7):1227. PubMed ID: 15209680
    [No Abstract]   [Full Text] [Related]  

  • 19. Using social media as an institutional resource: implications for the clinical nurse specialist.
    Barton AJ
    Clin Nurse Spec; 2011; 25(3):107-9. PubMed ID: 21483239
    [No Abstract]   [Full Text] [Related]  

  • 20. Darvon removed from the market.
    Willens JS
    Pain Manag Nurs; 2011 Mar; 12(1):1. PubMed ID: 21349443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.